- About Overview
- Diversity, Equity, and Inclusion
- Honors and Awards
- Facts and Figures
- Support the School
- Contact Us
- Organization Overview
- Dean’s Office
- Dean’s Office Overview
- PharmD Education Unit
- Office of Faculty Academic Affairs
- Office of Administration
- Pharmacy Practice Partnerships
- Department of Bioengineering and Therapeutic Sciences
- Department of Clinical Pharmacy
- Department of Pharmaceutical Chemistry
- Quantitative Biosciences Institute
- Org Chart
- Patient Care
Fujimori delivers 2017 Byers Award Lecture on tackling antibiotic resistance
By UCSF University Relations / Wed Feb 15, 2017
Since Alexander Fleming discovered penicillin in 1940, countless lives have been saved by antibiotics. But their effectiveness is severely compromised by the emergence of antibiotic resistant strains of bacteria, accelerated by the over-prescription of antibiotics and their widespread use as growth promoters in livestock farming.
With the failure of these drugs, routine procedures that depend on antibiotics—like hip replacements, cesareans, and organ transplants—may one day become too risky to perform.
The problem of antibiotic resistance and how research may help keep drugs effective was the topic of this year’s Byers Award Lecture in Basic Science, given by Danica Galonić Fujimori, PhD. Her January 31 talk was titled “Unlocking the Mystery of Antibiotic Resistance.”
The Byers Award in Basic Science is awarded annually to recognize and support the outstanding research of a mid-career faculty member.
Fujimori leads a group studying how bacteria acquire antibiotic resistance. She is an associate professor in the School of Medicine, Department of Cellular and Molecular Pharmacology and holds a joint appointment in the School of Pharmacy’s Department of Pharmaceutical Chemistry.
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.